Protalex

CONTACT US
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • PIPELINE
  • CLINICAL TRIALS
  • INVESTORS
  • MEDIA
  • CAREERS

CLINICAL TRIALS

 

Single-dose pharmacology of a single intravenous injection of purified PRTX-100 (Staphylococcal Protein A) in healthy adults: Part I. Safety, pharmacokinetics, and Immunogenicity
  
Interim Analysis of Safety, Pharmacology, and Immunogenicity of 4 weekly doses ofPRTX-100 in adult patients with ITP

 

contents

  • Overview
  • About Bioregulation
  • About PRTX-100
  • Clinical Trials
  • In Vivo Studies
  • Publications
  • Intellectual Property

Copyright © 2008 Protalex, Inc. All Rights Reserved.